Skip to content
Home/Companies/Pharma/Biose Industrie
Biose Industrie

Biose Industrie

Pharma·France·Exited 2024·Held 4yr
Entry
2020
Hold
4yr
Exit
2024

Who owns Biose Industrie?

Biose Industrie is a French Pharma company, now owned by L-GAM / BPI France, which acquired it in 2024 from Cathay Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap III · 2016 · Growth

Key facts

HQFrance
SectorPharma
Websitewww.biose.com
Exit Type
Trade Sale
Buyer
L-GAM / BPI France (French Tech Souveraineté)
Exit Year
2024

More from Cathay Capital Small Cap III

Other portfolio companies in the same fund.

Aukey
Aukey
Active
ConsumerChina· 2020
Brosmed
Active
MedTechChina· 2020
Deerma
Deerma
Active
ConsumerChina· 2020
EasyVista
EasyVista
Active
SaaSFrance· 2020
Fapon
Active
HealthcareChina· 2020
FuturMaster
FuturMaster
Active
SoftwareFrance· 2020

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Biose Industrie?

Biose Industrie is now owned by L-GAM / BPI France, which acquired it in 2024 from Cathay Capital.

When did L-GAM / BPI France acquire Biose Industrie?

L-GAM / BPI France acquired Biose Industrie in 2024, buying from Cathay Capital.

Who did Biose Industrie sell to?

Cathay Capital sold Biose Industrie to L-GAM / BPI France in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue